Evidence map›Paper›PMID 30970906›Full record

ArticlePolymers2017

A Novel Heterogalactan from Antrodia camphorata and Anti-Angiogenic Activity of Its Sulfated Derivative.

Yanqiu Liu, Yaqi Ding, Min Ye, Tao Zhu, Danbi Tian, Kan Ding

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Polymers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Evidence-Based Nutraceuticals Derived fromFoods (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. International journal of biological sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanqiu LiuGlycochemistry and Glycobiology Lab, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China. lyanqiu@mail.ustc.edu.cn.
Yaqi DingGlycochemistry and Glycobiology Lab, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China. 3481918100@njtech.edu.cn.
Min YeState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China. yemin@bjmu.edu.cn.
Tao ZhuNano Science and Technology Institute, University of Science and Technology of China, 96 Jin Zhai Road, Hefei 230026, China. zhut@ustc.edu.cn.
Danbi TianDepartment of Chemical and Molecular Engineering, Nanjing Tech University, 30 Puzhu South Road, Nanjing 211816, China. danbi@njtech.edu.cn.
Kan DingGlycochemistry and Glycobiology Lab, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China. dingkan@simm.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A heterogalactan, named ACW0, was extracted from

Indexed as

anti-angiogenesisAntrodia camphoratamannofucogalactansulfated polysaccharide

Identifiers

PMID30970906
PMCPMC6432100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.